CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset

by Per Damkier, Anders Kjærsgaard, Kimberly A. Barker, Deidre Cronin-Fenton, Anatasha Crawford, Ylva Hellberg, Emilius A. M. Janssen, Carl Langefeld, Thomas P. Ahern, Timothy L. Lash
Published 2017-08-01